Sign in

CIK 0001726445

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SEER
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821153150
Phone
+1 650-453-0000
Business address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065
Former names
Seer Biosciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,578
in 1 filing

Net −$3,578. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Endweiss Charles −$4K VP Financial Planning Analysis sold 2% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-17 Farokhzad Omid CEO and Chair of the Board Conversion +135,611 135,611
2021-02-17 Farokhzad Omid CEO and Chair of the Board Sale −135,611 $64.15 $8.7M 0
2021-02-17 Farokhzad Omid CEO and Chair of the Board Conversion · Class B Common Stock −219,130 1,303,478
2021-02-17 Farokhzad Omid CEO and Chair of the Board Conversion · Class B Common Stock −135,611 2,251,717
2021-02-16 Ronaghi Mostafa Director Grant or award · Stock Option (right to buy) +27,939 27,939
2021-02-01 OSTADAN OMEAD President & COO Grant or award +41,250 377,448
2021-02-01 OSTADAN OMEAD President & COO Grant or award · Employee Stock Option (right to buy) +41,250 41,250
2021-02-01 Horn David R. Chief Financial Officer Grant or award +34,125 230,966
2021-02-01 Horn David R. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +34,125 34,125
2021-02-01 Farokhzad Omid CEO and Chair of the Board Conversion +359,501 645,116
2021-02-01 Farokhzad Omid CEO and Chair of the Board Conversion +416,409 416,409
2021-02-01 Farokhzad Omid CEO and Chair of the Board Sale −313,369 $64.15 $20.1M 297,487
2021-02-01 Farokhzad Omid CEO and Chair of the Board Sale −359,501 $64.15 $23.1M 285,615
2021-02-01 Farokhzad Omid CEO and Chair of the Board Sale −416,409 $64.15 $26.7M 0
2021-02-01 Farokhzad Omid CEO and Chair of the Board Grant or award +87,000 384,487
2021-02-01 Farokhzad Omid CEO and Chair of the Board Conversion · Class B Common Stock −359,501 1,522,608
2021-02-01 Farokhzad Omid CEO and Chair of the Board Conversion · Class B Common Stock −416,409 2,387,328
2021-02-01 Farokhzad Omid CEO and Chair of the Board Grant or award · Employee Stock Option (right to buy) +87,000 87,000
2021-02-01 Invus Public Equities, L.P. 10% owner Sale −252,545 $64.15 $16.2M 5,588,366
2021-01-27 Farokhzad Omid CEO and Chair of the Board Exercise or conversion +309,313 $0.04 $13K 588,536

Page 13 of 17 · 337 trades